Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TCRX

TScan Therapeutics, Inc.

CIK 0001783328 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.78
↑ 0.00 (0.43%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$49.50M
P/E Ratio
-0.42
EPS
-1.00
Dividend Yield
Not covered
52W Position
3%
Beta
1.60

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.72
P/S
6.96
EV/Revenue
-2.51
ROE
-170.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 3%
$0.72$2.57

Latest Financials

2025-12-31 FY
Revenue
$10.32M
Net Income
-$129.77M
Total Assets
$228.79M
Free Cash Flow
-$139.73M

Recent news